Get a fast, science-first tour of what cyclodextrins can really do—right before CPHI.
We’ll cover practical formulation know-how for delivering small molecules and biologics, roles in vaccines and biotech workflows, and when CDs themselves are the active (think Sugammadex).
Expect data-driven examples, common pitfalls, and quick decision frameworks you can take straight to partner meetings.
If you’re heading to CPHI, this session will sharpen your talking points, help you spot real opportunities (and red flags) on the show floor, and give you the right questions to ask suppliers and CDMOs. Bring your use cases—we’ll keep it interactive and pragmatic.
Continue the conversation at CarboHyde’s booth 4S176 for deeper dives into your projects and what’s next in CD-enabled therapies.